Does LANSOPRAZOLE Cause Rebound acid hypersecretion? 1,713 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,713 reports of Rebound acid hypersecretion have been filed in association with LANSOPRAZOLE (Lansoprazole). This represents 2.8% of all adverse event reports for LANSOPRAZOLE.
1,713
Reports of Rebound acid hypersecretion with LANSOPRAZOLE
2.8%
of all LANSOPRAZOLE reports
231
Deaths
187
Hospitalizations
How Dangerous Is Rebound acid hypersecretion From LANSOPRAZOLE?
Of the 1,713 reports, 231 (13.5%) resulted in death, 187 (10.9%) required hospitalization, and 2 (0.1%) were considered life-threatening.
Is Rebound acid hypersecretion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LANSOPRAZOLE. However, 1,713 reports have been filed with the FAERS database.
What Other Side Effects Does LANSOPRAZOLE Cause?
Chronic kidney disease (32,517)
Acute kidney injury (16,359)
Renal failure (12,509)
End stage renal disease (9,734)
Renal injury (9,383)
Tubulointerstitial nephritis (3,860)
Death (2,517)
Gastrooesophageal reflux disease (2,482)
Off label use (2,183)
Nephrogenic anaemia (2,162)
What Other Drugs Cause Rebound acid hypersecretion?
ESOMEPRAZOLE (2,501)
OMEPRAZOLE (2,350)
PANTOPRAZOLE (1,581)
DEXLANSOPRAZOLE (1,160)
OMEPRAZOLE\SODIUM BICARBONATE (95)
RABEPRAZOLE (64)
RANITIDINE (29)
FAMOTIDINE (12)
ESOMEPRAZOLE\NAPROXEN (9)
Which LANSOPRAZOLE Alternatives Have Lower Rebound acid hypersecretion Risk?
LANSOPRAZOLE vs LANTHANUM
LANSOPRAZOLE vs LANTUS
LANSOPRAZOLE vs LANTUS SOLOSTAR
LANSOPRAZOLE vs LAPATINIB
LANSOPRAZOLE vs LAPATINIB DITOSYLATE